4-(trifluoromethoxy)benzaldehyde oxime | 150162-39-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 4-(trifluoromethoxy)benzaldehyde oxime
• 英文别名: p-(trifluoromethoxy)benzaldehyde oxime；p-Trifluoromethoxybenzaldehyde oxime；N-[[4-(trifluoromethoxy)phenyl]methylidene]hydroxylamine
• CAS: 150162-39-3
• 化学式: C₈H₆F₃NO₂
• mdl: MFCD00210176
• 分子量: 205.136
• InChiKey: SFLMISFBFTUVTD-UHFFFAOYSA-N

物化性质

• 熔点：
  41 °C
• 沸点：
  205.9±40.0 °C(Predicted)
• 密度：
  1.31±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.125
• 拓扑面积：
  41.8
• 氢给体数：
  1
• 氢受体数：
  6

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 安全说明：
  S26,S36
• 危险类别码：
  R36/37/38
• 海关编码：
  2928000090

SDS

Name:	4-(Trifluoromethoxy)benzaldehyde oxime 97% Material Safety Data Sheet
Synonym:
CAS:	150162-39-3

Section 1 - Chemical Product MSDS Name:4-(Trifluoromethoxy)benzaldehyde oxime 97% Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
150162-39-3	4-(Trifluoromethoxy)benzaldehyde oxime	97%	unlisted

Hazard Symbols: XI
Risk Phrases: 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 150162-39-3: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 41 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C8H6F3NO2
Molecular Weight: 205

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Reducing agents, bases, acid chlorides, oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 150162-39-3 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
4-(Trifluoromethoxy)benzaldehyde oxime - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 150162-39-3: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 150162-39-3 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 150162-39-3 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-(trifluoromethoxy)benzaldehyde oxime 在 盐酸 、 锌 作用下， 以 乙醇 、 水 为溶剂， 反应 1.0h， 以71%的产率得到4-(三氟甲氧基)苯甲胺
  参考文献：
  名称：

  新型三唑-氨基酸杂种对念珠菌生长和毒力的影响：体内和体外研究†

  摘要：

  越来越多的人类念珠菌的发病率和倾向念珠菌物种成为现有化疗耐药是公认的健康问题。本研究表明，新型三唑-氨基酸杂种的成功合成具有针对念珠菌的强大的体外和体内抑制活性。特别地，化合物68和70显示出对氟康唑（FLC）抗性以及白色念珠菌敏感临床分离株的有效体外活性。铅抑制剂68和70的时间杀灭曲线分析显示出它们的抑菌性质。在68和70的存在下，水解酶（主要是蛋白酶和磷脂酶）的分泌显着减少，表明它们对真菌毒力的干扰。暴露于化合物68和70的念珠菌细胞的TEM分析清楚地表明，形态变化和细胞内损伤是其可能的作用方式。对两种最有效的抑制剂（68和70）进行了初步的机理研究。）显示出麦角固醇生物合成的抑制作用，从而导致细胞丧失其完整性和生存能力。所选择的化合物在HEK293细胞系中直至200μgmL -1的浓度都没有显示出明显的细胞毒性。一个在硅片的分析68和70结合到建模C.白色念珠菌小号CYP51表明临

  DOI：

  10.1039/c6ob01718e
• 作为产物：
  描述：

  对三氟甲氧基苯甲醛 在 盐酸羟胺 、 sodium acetate 作用下， 以 甲醇 为溶剂， 反应 12.0h， 生成 4-(trifluoromethoxy)benzaldehyde oxime
  参考文献：
  名称：

  通过钴催化的C轻松获得1-氨基和1-碳取代的异喹啉？H / N ？O键活化

  摘要：

  用于从反应高度官能化的1-氨基和1-碳取代的异喹啉的合成绿色原子的经济的方法N'- hydroxybenzimidamides和芳基酮肟，分别与炔烃经由pentamethylcyclopentadienylcobalt（III）催化Ç  H /Ñ 描述了O键活化。外部无氧化剂环化反应在N'-羟基苯甲酰胺或N中使用= NOH部分-芳族酮肟为导向基团和内部氧化剂。该第一行过渡金属催化的环化反应可作为异喹啉合成的有效替代方法，因为水是唯一的副产物，且贵金属例如铑（III），铱（III），钯（II）和钌是贵金属（II）不是必需的。反应的进行通过Ç  ħ活化，炔插入，还原消除，和N  Ò活化。

  DOI：

  10.1002/adsc.201501056

文献信息

• Diversity Oriented Clicking (DOC): Divergent Synthesis of SuFExable Pharmacophores from 2‐Substituted‐Alkynyl‐1‐Sulfonyl Fluoride (SASF) Hubs
  作者：Christopher J. Smedley、Gencheng Li、Andrew S. Barrow、Timothy L. Gialelis、Marie‐Claire Giel、Alessandra Ottonello、Yunfei Cheng、Seiya Kitamura、Dennis W. Wolan、K. Barry Sharpless、John E. Moses

  DOI：10.1002/anie.202003219

  日期：2020.7.20

  Diversity Oriented Clicking (DOC) is a unified click‐approach for the modular synthesis of lead‐like structures through application of the wide family of click transformations. DOC evolved from the concept of achieving “diversity with ease” , by combining classic C−C π‐bond click chemistry with recent developments in connective SuFEx‐technologies. We showcase 2‐Substituted‐Alkynyl‐1‐Sulfonyl Fluorides

  面向多样性的点击 (DOC) 是一种统一的点击方法，用于通过应用广泛的点击转换家族来模块化合成类先导结构。DOC 从实现“轻松实现多样性”的概念演变而来，将经典的 C−C π 键点击化学与连接性 SuFEx 技术的最新发展相结合。我们展示了 2-取代的- A炔基-1-磺酰基F氟化物（SASFs）作为一类新的连接枢纽，与多种点击环加成过程相结合。通过具有一系列偶极子和环状二烯的 SASF 的选择性 DOC，我们以最少的合成步骤报告了 173 种独特功能分子的多样化点击库。SuFExable 库包含 10 个离散的杂环核心结构，这些核心结构源自 1,3- 和 1,5- 偶极子；而与环状二烯的反应会产生几种三维双环 Diels-Alder 加合物。通过对 96 孔板中的磺酰氟侧基进行 SuFEx 点击衍生化，可以通过后期修饰将文库增加到 278 种离散化合物——证明了 DOC 方法在快速合成不同功能结构方面的多功能性。
• Ruthenium-Catalyzed Rearrangement of Aldoximes to Primary Amides in Water
  作者：Rocío García-Álvarez、Alba E. Díaz-Álvarez、Javier Borge、Pascale Crochet、Victorio Cadierno

  DOI：10.1021/om3006917

  日期：2012.9.10

  The rearrangement of aldoximes to primary amides has been studied using the readily available arene-ruthenium(II) complex [RuCl2(η6-C6Me6)P(NMe2)3}] (5 mol %) as catalyst. Reactions proceeded cleanly in pure water at 100 °C without the assistance of any cocatalyst, affording the desired amides in high yields (70–90%) after short reaction times (1–7 h). The process was operative with both aromatic

  醛肟于伯酰胺的重排已使用容易获得的芳烃-钌（II）络合物将[RuCl研究2（η 6 -C 6我6）P（NME 2）3 }]（5摩尔％）作为催化剂。反应在纯水中于100°C干净地进行，无需任何助催化剂的帮助，在较短的反应时间（1-7小时）后，以高收率（70-90％）得到所需的酰胺。该方法对芳香族，杂芳香族，α，β-不饱和和脂肪族醛肟均有效，并能耐受多个官能团。使用18的反应曲线和实验O标记的水表明在这些转化中涉及两种不同的机制。在两者中，腈中间体最初都是通过醛肟的脱水而形成的。然后通过醛肟或水的第二分子的作用将这些中间体水合为相应的酰胺。还讨论了苯甲醛肟重排成苯甲酰胺的动力学分析。
• Continuous Platform To Generate Nitroalkanes On-Demand (in Situ) Using Peracetic Acid-Mediated Oxidation in a PFA Pipes-in-Series Reactor
  作者：Sergey V. Tsukanov、Martin D. Johnson、Scott A. May、Stanley P. Kolis、Matthew H. Yates、Jeffrey N. Johnston

  DOI：10.1021/acs.oprd.8b00113

  日期：2018.8.17

  of peroxides and nitroalkanes. The subsequent continuous extraction generates a solution of purified nitroalkane, which can be directly used in the following enantioselective aza-Henry chemistry to furnish valuable chiral diamine precursors with high selectivity, thus completely avoiding isolation of the potentially unsafe low-molecular-weight nitroalkane intermediate. A continuous campaign (16 h) established

  氮杂-亨利反应的合成效用可因与使用过酸制备硝基烷烃底物和硝基烷烃本身有关的潜在危害而在规模上减小。作为响应，报道了连续和可扩展的化学平台，其使用肟与过氧乙酸的氧化和硝基链烷中间体在aza-Henry反应中的直接反应按需制备脂肪族硝基链烷。独特设计的串联管式活塞流管反应器解决了一系列工艺难题，包括过氧化物和硝基烷的稳定性和安全处理。随后的连续萃取生成纯化的硝基烷溶液，可将其直接用于以下对映选择性aza-Henry化学中，以高选择性提供有价值的手性二胺前体，因此，完全避免了可能不安全的低分子量硝基烷中间体的分离。连续运动（16小时）证明这些条件对于处理100克肟和提供1.4升硝基烷溶液有效。
• Site selective synthesis and anti-inflammatory evaluation of Spiro-isoxazoline stitched adducts of arteannuin B
  作者：Javeed Ur Rasool、Gifty Sawhney、Majeed Shaikh、Yedukondalu Nalli、Sreedhar Madishetti、Zabeer Ahmed、Asif Ali

  DOI：10.1016/j.bioorg.2021.105408

  日期：2021.12

  A library of new spiroisoxazoline analogues of arteannuin B was synthesized through 1, 3-dipolar cycloaddition in stereoselective fashion and consequently screened for anti-inflammatory activity in RAW 264.7 macrophage cells. Three potent analogues (8i, 8 m, and 8n) were found to attenuate the LPS induced release of cytokines IL-6 and TNF-α more potently than the parent molecule. Also, the inhibition

  青蒿素 B 的新螺异恶唑啉类似物文库通过 1, 3-偶极环加成以立体选择性方式合成，因此筛选 RAW 264.7 巨噬细胞的抗炎活性。发现三种有效的类似物（8i、8m和8n）比母体分子更有效地减弱 LPS 诱导的细胞因子 IL-6 和 TNF-α 的释放。此外，在这些细胞中对 LPS 诱导的一氧化氮产生的抑制显示出中等至高效的功效。在孵育 48 小时后，这三种有效分子均未改变 RAW 264.7 细胞的活力，这表明细胞中表现出的细胞因子和一氧化氮产生的抑制不是由于毒性。此外，这些化合物的 IC 50范围为 0.17 µM-1.57 µM 和 0.09 µM-0.35 µM，分别用于抑制 IL-6 释放和一氧化氮产生。结果揭示了对促炎介质的有效抑制，这是令人鼓舞的并且值得进一步研究以开发用于炎性疾病的新治疗剂。
• Rearrangement of aldoximes to amides in water under air atmosphere catalyzed by water-soluble iridium complex [Cp*Ir(H₂O)₃][OTf]₂
  作者：Chunlou Sun、Panpan Qu、Feng Li

  DOI：10.1039/c3cy00934c

  日期：——

  [Cp*Ir(H2O)3][OTf]2, a variety of aldoximes, including aromatic, aliphatic, conjugated unsaturated and non-conjugated unsaturated, were converted into their corresponding amides in water with good to excellent yields. Further, the one-pot synthesis of amides from aldehydes, hydroxylamine hydrochloride and sodium carbonate via a tandem condensation–rearrangement reaction in water was also accomplished. Compared

  在水溶性铱络合物[Cp * Ir（H 2 O）3 ] [OTf] 2的存在下，包括芳族，脂肪族，共轭不饱和和非共轭不饱和在内的各种醛肟被转化为其相应的酰胺。在水中具有良好或优异的产量。此外，还通过串联缩合-重排反应在水中从醛，盐酸羟胺和碳酸钠一锅法合成酰胺。与报道的用于在水中将醛肟重排成酰胺的有机金属催化剂相比，本发明的催化剂显示出一些优点，例如不含磷配体，催化剂负载低以及在空气气氛下操作方便。